Clinical Trials on Platelets-rich Plasma in South Africa
Total 364 results
-
Senesco Technologies, Inc.UnknownMultiple Myeloma | Plasma Cell Leukemia | Multiple Myeloma in Relapse | Mantle Cell Lymphoma in Relapse | Diffuse Large B Cell Lymphoma in Relapse | Other B Cell Lymphoma in RelapseUnited States, South Africa
-
Vega Therapeutics, IncRecruitingVon Willebrand DiseasesUnited States, Austria, South Africa, United Kingdom
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple Myeloma | Non-Hodgkin's LymphomaIsrael, Italy, Poland, South Africa, United Kingdom
-
AstraZenecaCompletedInvestigation of Platelet Aggregation in Paediatric Patients With Sickle Cell DiseaseUnited States, Canada, United Kingdom, South Africa, Lebanon, Kenya
-
University of AthensPierre and Marie Curie UniversityRecruitingMultiple Myeloma | Venous ThromboembolismGreece
-
National Cancer Institute (NCI)CompletedDexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmUnited States, Puerto Rico, South Africa
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPure Red-cell AplasiaUnited Kingdom, Sweden, South Africa, Brazil, Canada, Germany, Norway, Thailand
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedMultiple Myeloma, Plasma Cell LeukemiaUnited States
-
CelgeneTerminatedPathologic Processes | Fibrosis | Respiratory Tract Diseases | Lung Diseases | Idiopathic Pulmonary Fibrosis | Lung Diseases, Interstitial | Idiopathic Interstitial PneumoniasUnited States, Australia, Colombia, United Kingdom, Russian Federation, Brazil, Germany, Canada, Greece, Romania, Taiwan, Turkey, Ukraine
-
GlaxoSmithKlineCompletedThrombocytopaeniaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Hellenic Society of HematologyTakeda; Janssen Pharmaceutica NVUnknown
-
Hellenic Society of HematologyJanssen PharmaceuticalsUnknown
-
OctapharmaCompletedPrevent Bleeding in Major SurgeryUnited States, Turkey, Romania, India, Bulgaria, Italy, Oman, Poland, South Africa
-
Hellenic Society of HematologyGlaxoSmithKlineActive, not recruiting
-
National Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
OncotherapeuticsUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPure Red-cell AplasiaUnited Kingdom, Sweden, South Africa, Brazil, Norway, France, Thailand
-
Leiden University Medical CenterAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Sanquin...RecruitingIntraventricular Hemorrhage | Neonatal Thrombocytopenia | Platelet TransfusionNetherlands, Sweden
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCWithdrawnRecurrent Plasma Cell MyelomaUnited States
-
Meletios A. DimopoulosCompleted
-
Hellenic Society of HematologyJanssen PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaGreece
-
Eisai Inc.CompletedImmune Thrombocytopenia | Chronic ThrombocytopeniaPoland, Ukraine, Belgium, Bulgaria, South Africa, Netherlands, New Zealand, Singapore, Australia, Slovakia, Czechia
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico
-
Medical University of South CarolinaGenentech, Inc.CompletedMultiple MyelomaUnited States
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Sheffield Teaching Hospitals NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Eisai Inc.TerminatedIdiopathic Thrombocytopenic PurpuraUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of CopenhagenActive, not recruiting
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedPain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative...United States
-
Prothena Biosciences Ltd.Amyloidosis Research Consortium; Amyloidosis Support Groups; Amyloidosis Foundation and other collaboratorsCompletedAL Amyloidosis | AmyloidosisUnited States
-
Medical University of South CarolinaWithdrawn
-
Meletios A. DimopoulosEuropean Myeloma NetworkCompletedWaldenstrom's MacroglobulinemiaSpain, Greece, Netherlands
-
Kartos Therapeutics, Inc.RecruitingPrimary Myelofibrosis (PMF) | Post-Polycythemia Vera Myelofibrosis (Post-PV-MF) | Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF)United States, Mexico, Bulgaria, Poland, Russian Federation, Belarus, Georgia, South Africa, Ukraine
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
Gary MorrowNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMultiple Myeloma | InfectionUnited States, Peru, South Africa
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Australia, New Zealand
-
Hoffmann-La RocheCompletedIdiopathic Thrombocytopenic PurpuraAustralia
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative DisorderUnited States
-
CSL LimitedCompletedIdiopathic Thrombocytopenic Purpura (ITP)Australia
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
University of Alabama at BirminghamAmgenCompletedMultiple MyelomaUnited States
-
Hoosier Cancer Research NetworkNovartis Pharmaceuticals; Walther Cancer InstituteTerminatedMultiple MyelomaUnited States
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
Imago BioSciences, Inc., a subsidiary of Merck...Active, not recruitingPrimary Myelofibrosis | Thrombocythemia, EssentialUnited States, Australia, Hong Kong, Germany, Italy, New Zealand, United Kingdom